MedPath

Pirarubicin

Generic Name
Pirarubicin
Drug Type
Small Molecule
Chemical Formula
C32H37NO12
CAS Number
72496-41-4
Unique Ingredient Identifier
D58G680W0G

Overview

No overview information available.

Indication

No indication information available.

Associated Conditions

No associated conditions information available.

Clinical Trials

Title
Posted
Study ID
Phase
Status
Sponsor
2024/12/03
Phase 2
Recruiting
2022/03/18
Not Applicable
Not yet recruiting
2019/04/24
N/A
UNKNOWN
Xijing Hospital
2019/03/27
Phase 4
Not yet recruiting
2017/11/14
Phase 2
Withdrawn
2016/10/04
Phase 2
UNKNOWN
2016/09/16
Phase 4
UNKNOWN
Hebei Medical University Fourth Hospital
2016/04/15
Phase 2
UNKNOWN
2015/11/24
Phase 3
Completed
307 Hospital of PLA
2015/10/23
Phase 2
Withdrawn
Guangxi Medical University

FDA Drug Approvals

Approved Product
Manufacturer
NDC Code
Route
Strength
Effective Date
No FDA approvals found for this drug.

EMA Drug Approvals

Approved Product
Authorization Holder
Status
Issued Date
No EMA approvals found for this drug.

HSA Drug Approvals

Approved Product
Manufacturer
Approval Number
Dosage Form
Strength
Approval Date
No HSA approvals found for this drug.

NMPA Drug Approvals

Approved Product
Company
Approval Number
Drug Type
Dosage Form
Approval Date
Pirarubicin Hydrochloride for Injection
国药准字H10930105
化学药品
注射剂(冻干)
2/12/2020
Pirarubicin Hydrochloride for Injection
国药准字H20045983
化学药品
注射剂
6/3/2020

PPB Drug Approvals

Approved Product
Registration No.
Company
Licence No.
Strength
Registration Date
No PPB approvals found for this drug.

TGA Drug Approvals

Approved Product
ARTG ID
Sponsor
Registration Type
Status
Registration Date
No TGA approvals found for this drug.

Help Us Improve

Your feedback helps us provide better drug information and insights.

© Copyright 2025. All Rights Reserved by MedPath